Optipharm.CO.,LTD is a company operating in the animal pharmaceuticals industry. The company offers animal diagnostic kits, examination services, and viral nutrition research and development. It has developed technologies for genetically modified transplant pigs and holds the record for the highest number of days of transplantation in the country. Optipharm.CO.,LTD.'s target market includes rural development agencies.

Headquarters
63, Oseongsaengmyeong 6-Ro, Osong-Eup, Heungdeok-Gu, Cheongju-Si, Chungcheongbuk-Do
Cheongju; Chungcheongbuk;

Contact Details: Purchase the Optipharm Co.,Ltd report to view the information.

Website: http://www.optipharm.co.kr

Basic Information

Total Employees:

Purchase the Optipharm Co.,Ltd report to view the information.

Outstanding Shares:

Purchase the Optipharm Co.,Ltd report to view the information.

Registered Capital:

Purchase the Optipharm Co.,Ltd report to view the information.

Financial Auditors:

Purchase the Optipharm Co.,Ltd report to view the information.

Incorporation Date:

July 27, 2000

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Ownership Details

Purchase this report to view the information.

31.5%

Purchase this report to view the information.

4.2%

Purchase this report to view the information.

2.8%

Subsidiaries

주식회사 옵티팜

Company Performance

Financial values in the chart are available after Optipharm Co.,Ltd report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

16.7%▲

Total Operating Revenue

16.77%▲

Operating Profit

5.96%▲

EBITDA

17.97%▲

Net Profit/Loss for the Period

-1.34%▼

Total Assets

7.85%▲

Total Equity

9.73%▲

Operating Profit Margin

3.01%▲

Net Profit Margin

1.99%▲

Return on Equity (ROE)

0.69%▲

Debt / Equity

-6474%▼

Quick Ratio

-381.08%▼

Cash Ratio

-0.44%▼

Optipharm Co.,Ltd (South Korea)

Similar companies